Dyanavel XR (Tris Pharma Inc)
Welcome to the PulseAid listing for the Dyanavel XR drug offered from Tris Pharma Inc. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Tris Pharma Inc |
NON-PROPRIETARY NAME: | amphetamine |
SUBSTANCE NAME: | AMPHETAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-01 |
END MARKETING DATE: | 0000-00-00 |
Dyanavel XR HUMAN PRESCRIPTION DRUG Details:
Item Description | Dyanavel XR from Tris Pharma Inc |
LABELER NAME: | Tris Pharma Inc |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 2.5(mg/mL) |
START MARKETING DATE: | 2015-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 27808-102_4b80fde6-331f-4ac9-a21a-1ea0f7213de2 |
PRODUCT NDC: | 27808-102 |
APPLICATION NUMBER: | NDA208147 |
Other AMPHETAMINE Pharmaceutical Manufacturers / Labelers: